Skip to main content
SpringerLink
Log in

Role of Dietary Supplements on Mental Function

  • Chapter
  • First Online:
Food and Human Responses

  • 380 Accesses

Abstract

The chapter would principally discuss the role of dietary supplements on mental function. There would also be a discussion on the definition of dietary supplements, the norms of US Food and Drug Administration 1994, safety of dietary supplements, the role of fish oil supplements, and the interrelationship between fish oil supplements and cognitive decline. The place of herbals and botanicals in human health will also form part of the discussion in the chapter. Additionally, there would also be a discussion on the various antioxidants.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Barrett, B., Kiefer, D., & Rabago, D. (1999). Assessing the risks and benefits of herbal medicine: An overview of scientific evidence. Alternative Therapies in Health and Medicine, 5, 40–49.

    CAS  PubMed  Google Scholar 

  • Bent, S., Goldberg, H., Padula, A., & Avins, A. L. (2005). Spontaneous bleeding associated with Ginkgo biloba: A case report and systematic review of the literature. Journal of General Internal Medicine, 20, 657–661.

    Article  Google Scholar 

  • Bent, S., Padula, A., Moore, D., Patterson, M., & Mehling, W. (2006). Valerian for sleep: A systematic review and meta-analysis. American Journal of Medicine, 119, 1005–1012.

    Article  Google Scholar 

  • Benton, D. (2002). Selenium intake, mood and other aspects of psychological functioning. Nutritional Neuroscience, 5, 363–374.

    Article  CAS  Google Scholar 

  • Carlsen, M. H., Halvorsen, B. L., Holte, K., Bohn, S. K., & Draglund, S. (2010). The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutrition Journal, 9, 3.

    Article  Google Scholar 

  • Cohen, P. A. (2012). DMAA as a dietary supplement ingredient. Archives of Internal Medicine, 172, 1038–1039.

    PubMed  Google Scholar 

  • ConsumerLab. com. (2010). Survey of vitamin and supplement users. Available at: http://www.consumerlab.com/news/Supplement_Survey_Report/1_31_2010. Accessed 25 Mar 2015

  • Cunnane, S. C., Plourde, M., Pifferi, F., Begin, M., Feart, C., & Barberger-Gateau, P. (2009). Fish, docosahexaenoic acid and Alzheimer’s disease. Progress in Lipid Research, 48, 239–256.

    Article  CAS  Google Scholar 

  • Engelhart, M. J., Geelings, M. I., Ruitenberg, A., van Swieten, J. C., Hofman, A., Witteman, J. C., & Breteler, M. M. (2002). Dietary intake of antioxidants and risk of Alzheimer disease. Journal of the American Medical Association, 287, 3223–3229.

    Article  CAS  Google Scholar 

  • Ernst, E. (2002). The risk-benefit profile of commonly used herbal therapies: Ginkgo, St John’s Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Annals of Internal Medicine, 136, 42–53.

    Article  Google Scholar 

  • Etminan, M., Gill, S. S., & Samii, A. (2005). Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson’s disease: A meta-analysis. The Lancet Neurology, 4, 362–365.

    Article  CAS  Google Scholar 

  • Fahn, S. (1991). An open trial of high-dosage antioxidants in early Parkinson’s disease. American Journal of Clinical Nutrition, 53, 380S–382S.

    Article  CAS  Google Scholar 

  • Farris, M. W., & Zhang, J. G. (2003). Vitamin E therapy in Parkinson’s disease. Toxicology, 189, 129–146.

    Article  Google Scholar 

  • Fenten, W. S., Dickerson, F., Boronow, J., Hibbeln, J. R., & Knable, M. (2001). A placebo-controlled trial of omega 3-fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. American Journal of Psychiatry, 158, 2071–2074.

    Article  Google Scholar 

  • Food and Nutrition Board, Institute of Medicine and National Academy of Sciences. (2000). Dietary reference intakes for vitamin C, vitamin E, selenium and carotinoids. Washington, DC: National Academy Press.

    Google Scholar 

  • Forgo, I., & Schimert, G. (1985). The duration of effect of the standardized ginseng extract G 115 in healthy competitive athletes. Notabene Medici, 15, 636–640.

    Google Scholar 

  • Fugh-Berman, A., & Cott, J. M. (1999). Dietary supplements and natural products as psychotherapeutic agents. Psychosomatic Medicine, 61, 712–728.

    Article  CAS  Google Scholar 

  • Grey, A., & Bolland, M. (2014). Research letter: Clinical trial evidence and use of fish oil supplements. JAMA Internal Medicine, 174, 460–462.

    Article  Google Scholar 

  • Grundman, M., & Delaney, P. (2002). Antioxidant strategies for Alzheimer’s disease. Proceedings of the Nutrition Society, 61, 191–202.

    Article  CAS  Google Scholar 

  • Hoang, M. T., DeFina, L. F., & Willis, B. L. (2011). Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: The cooper center longitudinal study. Mayo Clinic Proceedings, 86, 1050–1055.

    Article  CAS  Google Scholar 

  • Hozl, J., & Godau, P. (1989). Receptor binding studies and Valeriana officinalis on the benzodiazepine receptor. Planta Medica, 55, 642.

    Google Scholar 

  • Hypericum Depression Trial Study Group. (2002). Effect of Hypericum perforatum (St John’s wort) in major depressive disorder: A randomized controlled trial. Journal of the American Medical Association, 287, 1807–1814.

    Article  Google Scholar 

  • Izzo, A. (2005). Herb-drug interactions: An overview of the critical evidence. Fundamentals of Clinical Pharmacology, 19, 1–16.

    Article  CAS  Google Scholar 

  • Kotani, S., Sakaguchi, E., Warashina, S., Matsukawa, N., & Ishikura, Y. (2006). Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neuroscience research, 56, 159–164.

    Article  CAS  Google Scholar 

  • Kunhn, W., Roebroek, R., Blom, H., van Oppenraaij, D., Przuntek, H., Kretschmer, A., Buttner, T., Woitalla, D., & Muller, T. (1998). Elevated plasma levels of homocysteine in Parkinson’s didease. European Neurology, 40, 225–227.

    Article  Google Scholar 

  • Le Boeuf, R. (2003). Homocysteine and Alzheimer’s disease. Journal of the American Dietetic Association, 103, 304–307.

    Article  Google Scholar 

  • Lieberman, H. R. (2001). The effects of ginseng, ephedrine, and caffeine on cognitive performance, mood and energy. Nutrition Reviews, 59, 91–102.

    Article  CAS  Google Scholar 

  • Peet, M., & Horrobin, D. F. (2002). A close-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Archives of General Psychiatry, 59, 913–919.

    Article  CAS  Google Scholar 

  • Peet, M., Brind, J., Ramchand, C. N., Shash, S., & Vankar, G. K. (2001). Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizophrenia Research, 49, 243–251.

    Article  CAS  Google Scholar 

  • Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., & Doody, R. (2005). Vitamin E and donepezil for the treatment of mild cognitive impairment. New England Journal of Medicine, 352, 2379–2388.

    Article  CAS  Google Scholar 

  • Pittler, M. H., & Ernst, E. (2003). Kava extract for treating anxiety. The Cochrane Database of Systematic Reviews, 1, CD003383. https://doi.org/10.1002/14651858.CD003383.

    Article  Google Scholar 

  • Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., & Schafer, K. (1997). A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. The Alzheimer’s disease cooperative study. New England Journal of Medicine, 336, 1216–1222.

    Article  CAS  Google Scholar 

  • Snitz, B. E., O’meara, E. S., Carlson, M. C., Arnold, A. M., & Ives, D. G. (2009). Ginkgo biloba for preventing cognitive decline in older adults: A randomized trial. Journal of the American Medical Association, 302, 2663–2670.

    Article  CAS  Google Scholar 

  • Spedding, S. (2014). Vitamin D and depression: A systematic review and meta-analysis comparing studies with and without biological flaws. Nutrients, 6, 1501–1518.

    Article  CAS  Google Scholar 

  • Su, K.-P., Huang, S.-H., Chiu, C.-C., & Shen, W. W. (2003). Omega-3 fatty acids in major depressive disorder: A preliminary double-blind, placebo-controlled trial. European Neuropsychopharmacology, 13, 267–271.

    Article  CAS  Google Scholar 

  • Suzuki, H., Morikawa, Y., & Takahashi, H. (2001). Effect of DHA oil supplementation on intelligence and visual acuity in the elderly. World Review of Nutrition and Dietetics, 88, 68–71.

    Article  CAS  Google Scholar 

  • Swerdlow, J. L. (2000). Modern science embraces medicinal plants. In J. L. Swerdlow (Ed.), Nature’s medicine: A chronicle of mankind’s search for healing plants through the ages (pp. 110–157). Washington, DC: National Geographic Society.

    Google Scholar 

  • Sydenham, E., Dangour, A. D., & Lim, W. S. (2012). Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database of Systematic Reviews, 6, CD005379. https://doi.org/10.1002/14651858.CD005379.pub3.

    Article  Google Scholar 

  • Taibi, D. M., Landis, C. A., Petry, H., & Vitiello, M. V. (2007). A systematic review of valerian as a sleep aid: Safe but not effective. Sleep Medicine Reviews, 11, 209–230.

    Article  Google Scholar 

  • Thorpe, B. (2013). Northern mythology, comprising the principal popular traditions and superstitions of Scandinavia, northern Germany and the Netherlands (Vol. 2). London: Forgotten Books. (Original work published 1851).

    Google Scholar 

  • US Food and Drug Administration. (1994). Dietary supplement and health education act of 1994. Available at: http://www.fda.gov/Regulatory Information/Legislation/FederalFoodDrugand CosmeticActFDCAct/Significant Amendments to the FDCA Act/ucm 1 480003.htm. Accessed 30 June 2015

    Google Scholar 

  • US Food and Drug Administration, Center for Food Safety and Applied Nutrition. (2002). Consumer advisory: Kava-containing dietary supplements may be associated with severe liver damage. Available at: http://www.fda.Gov/foodresourcesforyou/consumers/ucm085482.htm. Accessed 25 Mar 2015

  • Vogler, B. K., Pittler, M. H., & Ernst, E. (1999). The efficacy of ginseng. A systematic review of randomized clinical trials. European Journal of Clinical Pharmacology, 55, 567–575.

    Article  CAS  Google Scholar 

  • Wainwright, P. E. (2002). Dietary essential fatty acids and brain function: A developmental perspective on mechanisms. Proceedings of the Nutrition Society, 61, 61–69.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Villament G3, C/o Dr. Mavila Pankajakshy, Malaparamba, Kozhikode, Kerala, India

    Kodoth Prabhakaran Nair

Authors
  1. Kodoth Prabhakaran Nair
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nair, K.P. (2020). Role of Dietary Supplements on Mental Function. In: Food and Human Responses . Springer, Cham. https://doi.org/10.1007/978-3-030-35437-4_8

Download citation

Publish with us

Policies and ethics

Search

Navigation